Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) where stereochemistry plays a critical role in biological activity. Its structure serves as a key intermediate in the production of certain anticancer agents, antiviral drugs, and central nervous system therapeutics. The (R)-enantiomer’s specific configuration allows for selective interactions in biological systems, enhancing drug efficacy and reducing side effects. It is also employed in the preparation of catalysts and ligands for asymmetric synthesis, supporting the creation of enantiomerically pure compounds in medicinal chemistry research.